I had radiation and then started Brukinsa.
July 18
Insurance denials for BRUKINSA (zanubrutinib) as a first-line treatment are unfortunately common, and you're not alone in facing this frustration. Many MyLymphomaTeam members have shared similar experiences with prior authorization hurdles.
From a clinical standpoint, BRUKINSA is currently FDA-approved for lymphoma, but Show Full Answer
Insurance denials for BRUKINSA (zanubrutinib) as a first-line treatment are unfortunately common, and you're not alone in facing this frustration. Many MyLymphomaTeam members have shared similar experiences with prior authorization hurdles.
From a clinical standpoint, BRUKINSA is currently FDA-approved for lymphoma, but typically in cases where at least one prior treatment has already been tried. This is likely why your insurance pushed back. Here are some steps worth considering:
- Appeal the denial — Your doctor can submit a Letter of Medical Necessity explaining why BRUKINSA is the right choice for your specific situation
- Ask about a peer-to-peer review — Your oncologist can speak directly with the insurance company's medical reviewer
- Explore manufacturer assistance — BeiGene, the maker of BRUKINSA, offers a patient assistance program that may help cover costs while you appeal
- Ask about clinical trials — These can sometimes provide access to treatments without insurance barriers
Working closely with your oncology team's insurance navigator or social worker can make a big difference in getting this resolved. Don't give up — appeals are often successful!
May 29
Join
Your Privacy Choices
